{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:46:05Z","timestamp":1792431965226,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","award":["81602606"],"award-info":[{"award-number":["81602606"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bbrc.2021.09.069","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T14:50:04Z","timestamp":1632754204000},"page":"7-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Mefloquine as a dual inhibitor of glioblastoma angiogenesis and glioblastoma via disrupting lysosomal function"],"prefix":"10.1016","volume":"580","author":[{"given":"Bing","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3082-2967","authenticated-orcid":false,"given":"Xiulan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2021.09.069_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.wneu.2018.04.022","article-title":"Challenges in the treatment of glioblastoma: multisystem mechanisms of therapeutic resistance","volume":"116","author":"Noch","year":"2018","journal-title":"World Neurosurg."},{"key":"10.1016\/j.bbrc.2021.09.069_bib2","doi-asserted-by":"crossref","first-page":"101896","DOI":"10.1016\/j.ctrv.2019.101896","article-title":"Molecular targeted therapy of glioblastoma","volume":"80","author":"Le Rhun","year":"2019","journal-title":"Canc. Treat Rev."},{"key":"10.1016\/j.bbrc.2021.09.069_bib3","first-page":"180","article-title":"Bevacizumab and glioblastoma: past, present, and future directions","volume":"24","author":"Kim","year":"2018","journal-title":"Canc. J."},{"key":"10.1016\/j.bbrc.2021.09.069_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/13543784.2019.1650019","article-title":"The evolving role of antiangiogenic therapies in glioblastoma multiforme: current clinical significance and future potential","volume":"28","author":"Anthony","year":"2019","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.bbrc.2021.09.069_bib5","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.1105787","article-title":"Mefloquine (WR 142,490) in the treatment of human malaria","volume":"190","author":"Trenholme","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2021.09.069_bib6","doi-asserted-by":"crossref","first-page":"17031","DOI":"10.1038\/nmicrobiol.2017.31","article-title":"Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis","volume":"2","author":"Wong","year":"2017","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.bbrc.2021.09.069_bib7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/cbdd.12210","article-title":"Mefloquine-oxazolidine derivatives: a new class of anticancer agents","volume":"83","author":"Rodrigues","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bbrc.2021.09.069_bib8","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.tranon.2019.06.001","article-title":"Lysosome inhibition by mefloquine preferentially enhances the cytotoxic effects of tyrosine kinase inhibitors in blast phase chronic myeloid leukemia","volume":"12","author":"Lam Yi","year":"2019","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbrc.2021.09.069_bib9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.bbrc.2016.01.046","article-title":"Mefloquine effectively targets gastric cancer cells through phosphatase-dependent inhibition of PI3K\/Akt\/mTOR signaling pathway","volume":"470","author":"Liu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2021.09.069_bib10","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3892\/ol.2013.1211","article-title":"Mefloquine exerts anticancer activity in prostate cancer cells via ROS-mediated modulation of Akt, ERK, JNK and AMPK signaling","volume":"5","author":"Yan","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbrc.2021.09.069_bib11","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3892\/ol.2013.1259","article-title":"Mefloquine induces cell death in prostate cancer cells and provides a potential novel treatment strategy","volume":"5","author":"Yan","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbrc.2021.09.069_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1139\/cjpp-2016-0124","article-title":"Therapeutic effects of antibiotic drug mefloquine against cervical cancer through impairing mitochondrial function and inhibiting mTOR pathway","volume":"95","author":"Li","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.bbrc.2021.09.069_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.canlet.2012.07.029","article-title":"Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent","volume":"326","author":"Sharma","year":"2012","journal-title":"Canc. Lett."},{"key":"10.1016\/j.bbrc.2021.09.069_bib14","first-page":"473","article-title":"Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent","volume":"12","author":"Geng","year":"2010","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.bbrc.2021.09.069_bib15","first-page":"208","article-title":"Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas","volume":"39","author":"Mudassar","year":"2020","journal-title":"J.\u00a0Exp. Clin. Canc. Res. : CR (Clim. Res.)"},{"key":"10.1016\/j.bbrc.2021.09.069_bib16","first-page":"39","article-title":"Isolation and culture of microvascular endothelial cells from gliomas of different WHO grades","volume":"76","author":"Miebach","year":"2006","journal-title":"J.\u00a0Neuro-oncol."},{"key":"10.1016\/j.bbrc.2021.09.069_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161496","article-title":"Development and validation of a histological method to measure microvessel density in whole-slide images of cancer tissue","volume":"11","author":"Marien","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.bbrc.2021.09.069_bib18","first-page":"13","article-title":"Glioma-associated endothelial cells are chemoresistant to temozolomide","volume":"95","author":"Virrey","year":"2009","journal-title":"J.\u00a0Neuro-oncol."},{"key":"10.1016\/j.bbrc.2021.09.069_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00228-006-0247-3","article-title":"Population pharmacokinetics of mefloquine in military personnel for prophylaxis against malaria infection during field deployment","volume":"63","author":"Charles","year":"2007","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbrc.2021.09.069_bib20","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.3389\/fonc.2020.01217","article-title":"Mefloquine inhibits esophageal squamous cell carcinoma tumor growth by inducing mitochondrial autophagy","volume":"10","author":"Xie","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2021.09.069_bib21","first-page":"2881","article-title":"A\u00a0comparison of CD105 and CD31 expression in tumor vessels of hepatocellular carcinoma by tissue microarray and flow cytometry","volume":"16","author":"Qian","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbrc.2021.09.069_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1172\/JCI64180","article-title":"Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors","volume":"123","author":"Sukhai","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2021.09.069_bib23","doi-asserted-by":"crossref","first-page":"3749157","DOI":"10.1155\/2017\/3749157","article-title":"Lysosomes as oxidative targets for cancer therapy","volume":"2017","author":"Dielschneider","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbrc.2021.09.069_bib24","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1200\/JCO.2014.55.9575","article-title":"Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma","volume":"33","author":"Lu-Emerson","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbrc.2021.09.069_bib25","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/cncr.31811","article-title":"Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma","volume":"125","author":"Maraka","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2021.09.069_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.66","article-title":"Mefloquine, an anti-malaria agent, causes reactive oxygen species-dependent cell death in mast cells via a secretory granule-mediated pathway","volume":"2","author":"Paivandy","year":"2014","journal-title":"Pharmacol. Res. Perspect."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21013711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21013711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:41:25Z","timestamp":1762094485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X21013711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":26,"alternative-id":["S0006291X21013711"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.09.069","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mefloquine as a dual inhibitor of glioblastoma angiogenesis and glioblastoma via disrupting lysosomal function","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.09.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}